Literature DB >> 21031340

Are there gender-specific differences concerning quality of life in treated acromegalic patients?

T Psaras1, J Honegger, B Gallwitz, M Milian.   

Abstract

OBJECTIVE: Acromegaly is associated with deleterious comorbidities that can remain irreversible even after successful cure has been achieved and lead to a persistently impaired Quality of Life (QoL). The aim of the study was to assess frequency and degree of persistent comorbidities and complaints after treatment of acromegaly and to investigate their impact on QoL. Another scope of interest was to determine gender-specific factors that influence perceived QoL in men and women.
METHODS: We developed an Acromegaly Comorbidities & Complaints Questionnaire (ACCQ) consisting of 8 items (e. g. acral enlargement, joint complaints, hypertension, diabetes) known to affect QoL in order to assess frequency and degree of comorbidities. Additionally, the Acromegaly Quality of Life Questionnaire (AcroQoL) and the Short-form 36 (SF-36) questionnaire were handed out to 55 treated acromegalic patients.
RESULTS: Both genders suffer from a lasting impairment in quality of life to a considerable degree. Complaints impairing manual skills (e. g. acral enlargement, arthralgias) were the most frequent findings (73% of all participants) in both genders. Multivariate analyses revealed that in men numbness of fingers and persistent joint-complaints were decisively responsible for impaired QoL. In women, it was the persistence of hypertension.
CONCLUSIONS: Persistent joint complaints have adverse effects on QoL after treatment of acromegaly in men, possibly because they lead to impairment of manual motor skills and a handicap in their working life. Women seem to perceive late effects of hypertension as a manifest health threat. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 21031340     DOI: 10.1055/s-0030-1267912

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  9 in total

1.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

2.  Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.

Authors:  Silvia Vandeva; Maria Yaneva; Emil Natchev; Atanaska Elenkova; Krasimir Kalinov; Sabina Zacharieva
Journal:  Endocrine       Date:  2015-01-06       Impact factor: 3.633

Review 3.  Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.

Authors:  Cornelie D Andela; Margreet Scharloo; Alberto M Pereira; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

4.  Quality of life in female patients with acromegaly.

Authors:  O Celik; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

5.  Patient-focussed outcomes in acromegaly.

Authors:  Mirtha Guitelman; Alin Abreu; Ana Laura Espinosa-de-los-Monteros; Moisés Mercado
Journal:  Pituitary       Date:  2014-01       Impact factor: 4.107

Review 6.  Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.

Authors:  Victor J Geraedts; Cornelie D Andela; Günter K Stalla; Alberto M Pereira; Wouter R van Furth; Caroline Sievers; Nienke R Biermasz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-03       Impact factor: 5.555

7.  Executive functioning and quality of life in acromegaly.

Authors:  Emilia Solomon; Dumitru Brănișteanu; Andrei Dumbravă; Radu Gheorghe Solomon; Lorànt Kiss; Mihai Glod; Cristina Preda
Journal:  Psychol Res Behav Manag       Date:  2019-01-03

8.  Importance of Illness Acceptance Among Other Factors Affecting Quality of Life in Acromegaly.

Authors:  Aleksandra Jawiarczyk-Przybyłowska; Dorota Szcześniak; Marta Ciułkowicz; Marek Bolanowski; Joanna Rymaszewska
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-14       Impact factor: 5.555

Review 9.  Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.

Authors:  P Maffei; F Dassie; S Camerini; A Wennberg; M Adriani; B Martin; R Vettor
Journal:  J Endocrinol Invest       Date:  2022-03-23       Impact factor: 5.467

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.